(Total Views: 132)
Posted On: 02/07/2023 12:44:36 PM
Post# of 89355

$LIXT News Article - LIXTE BIOTECHNOLOGY HOLDINGS, INC. REPORTS THAT ITS LEAD CLINICAL COMPOUND, LB-100, CAN KILL CANCER CELLS THROUGH HYPER-STIMULATION OF CELL PROLIFERATION SIGNALS IN PRE-CLINICAL MODELS https://marketwirenews.com/news-releases/lixt...18697.html


My Twitter: WhyteStocks